![(2R,4R,5R,6R)-5-acetamido-2-[[(2S,3S,4R,5S,6S)-5-acetamido-3-hydroxy-6-(4-nitrophenoxy)-4-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydropyra](https://static.cymitquimica.com/cas-image/340445-2r-4r-5r-6r-5-acetamido-2-2s-3s-4r-5s-6s-5-acetamido-3-hydroxy-6-4-nitrophenoxy-4-2r-3s-4s-5r-6s-345-trihydroxy-6-hydroxymethyl-tetrahydropyran-2-yl-oxy-tetrahydropyran-2-yl-methoxy-4-hydroxy-6-1r-2r-123-trihydroxypropyl-tetrahydropyra.png)
CAS: 754954-71-7 - (2R,4R,5R,6R)-5-acetamido-2-[[(2S,3S,4R,5S,6S)-5-acetamido-3-hydroxy-6-(4-nitrophenoxy)-4-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydropyra
Formel:C31H45N3O21
InChl:InChI=1/C31H45N3O21/c1-11(37)32-19-15(39)7-31(30(46)47,55-27(19)21(41)16(40)8-35)50-10-18-23(43)26(54-29-25(45)24(44)22(42)17(9-36)52-29)20(33-12(2)38)28(53-18)51-14-5-3-13(4-6-14)34(48)49/h3-6,15-29,35-36,39-45H,7-10H2,1-2H3,(H,32,37)(H,33,38)(H,46,47)/t15-,16-,17+,18+,19-,20+,21-,22+,23-,24+,25+,26-,27-,28-,29+,31-/m1/s1
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP REF: 3D-EFB95471CAS: 754954-71-7 | Min. 95% | Nachfragen | Do 11 Jul 24 |
![Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP](https://static.cymitquimica.com/products/3D/thumb/EFB95471.jpg)
Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP
CAS:754954-71-7
Galβ(1-3)[neu5acα(2-6)]GlcNAc-β-PNP is a glycosylation product of the complex carbohydrate GlcNAc. It is synthesized by the …
Formel:
C31H45N3O21
Reinheit:
Min. 95%
Molekulargewicht:
795.7 g/mol
Ref: 3D-EFB95471
| 1mg | Nachfragen | |
| 5mg | Nachfragen | |
| 10mg | Nachfragen | |
| 25mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 11. Juli 2024
